Ceftriaxone Sodium
24 NDCs across 3 manufacturers|24 Generic,0 Brand
Ceftriaxone Sodium is used to treat acinetobacter infections, bacteroidaceae infections, infectious bone diseases, chancroid, clostridium infections and enteritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 21, 1984, and the first generic was approved Mar 12, 1985. In 2024, Medicare Part D spent $22 million on Ceftriaxone Sodium across 354,000 claims for 158,000 beneficiaries.
Ceftriaxone Sodium is available as 24 NDCs from 3 manufacturers (24 generic, 0 brand), with NADAC prices from $0.86 to $25.21 per EA — the most expensive product costs about 29× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
24
24G / 0B
Manufacturers
3
competing in market
Price Spread
$0.86 – $25.21
per EA
7d Activity
avg +1.5% WoW · of 24 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hospira Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cephalosporin Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing CEFTRIAXONE SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CEFTRIAXONE 10 GM VIAL | $25.2133 per EA | — |
CEFTRIAXONE 10 GM VIAL | $25.2133 per EA | — |
CEFTRIAXONE 1 GM VIAL | $3.4500 per EA | — |
CEFTRIAXONE 1 GM VIAL | $3.4500 per EA | — |
CEFTRIAXONE 2 GM VIAL | $2.8330 per EA | +4.93% |
CEFTRIAXONE 2 GM VIAL | $2.8330 per EA | +4.93% |
CEFTRIAXONE 2 GM VIAL | $2.8330 per EA | +4.93% |
CEFTRIAXONE 2 GM VIAL | $2.8330 per EA | +4.93% |
CEFTRIAXONE 500 MG VIAL | $1.8422 per EA | +1.92% |
CEFTRIAXONE 500 MG VIAL | $1.8422 per EA | +1.92% |
CEFTRIAXONE 500 MG VIAL | $1.3139 per EA | +1.26% |
CEFTRIAXONE 500 MG VIAL | $1.3139 per EA | +1.26% |
CEFTRIAXONE 500 MG VIAL | $1.3139 per EA | +1.26% |
CEFTRIAXONE 500 MG VIAL | $1.3139 per EA | +1.26% |
CEFTRIAXONE 250 MG VIAL | $1.2533 per EA | — |
CEFTRIAXONE 250 MG VIAL | $1.2533 per EA | — |
CEFTRIAXONE 1 GM VIAL | $1.1732 per EA | -1.86% |
CEFTRIAXONE 1 GM VIAL | $1.1732 per EA | -1.86% |
CEFTRIAXONE 1 GM VIAL | $1.1732 per EA | -1.86% |
CEFTRIAXONE 1 GM VIAL | $1.1732 per EA | -1.86% |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
CEFTRIAXONE 250 MG VIAL | $0.8622 per EA | — |
Frequently Asked Questions
What is Ceftriaxone Sodium used to treat?
Ceftriaxone Sodium is used to treat acinetobacter infections, bacteroidaceae infections, infectious bone diseases, chancroid, clostridium infections and enteritis, per the National Library of Medicine's MED-RT classification.
When did Ceftriaxone Sodium become available as a generic?
FDA approved the first generic Ceftriaxone Sodium (ANDA) on Mar 12, 1985.
How much does Medicare spend on Ceftriaxone Sodium?
In 2024, Medicare Part D spent $22 million on Ceftriaxone Sodium across 354,000 claims for 158,000 beneficiaries.
How many Ceftriaxone Sodium products are on the market?
The Ceftriaxone Sodium drug market contains 24 NDCs from 3 manufacturers — 24 generic and 0 brand products.
What is the price range for Ceftriaxone Sodium?
NADAC reference prices for Ceftriaxone Sodium range from $0.8622 to $25.2133 per EA — the most expensive product costs about 29× the cheapest.
Which manufacturers make Ceftriaxone Sodium?
3 manufacturers list Ceftriaxone Sodium in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (9), Sandoz Inc. (8), Apotex Corp. (7).
How has the price of Ceftriaxone Sodium changed recently?
Over the past 7 days, 10 Ceftriaxone Sodium NDCs rose and 4 fell, with a market-wide average change of +1.5%.